Skip to content

Posts for Category: Clinical

Get the latest news and read stories from across the country.

Welcome to our blog, where you can stay up to date with all the latest Pharmacy Alternatives news.

New Drug: Bagsimi

The FDA has approved the first nasally administered glucagon product (Baqsimi), for the treatment of severe hypoglycemia for patients aged 4... Read more »

A Risk Factor for Depression in People with Autism

Depression rates were higher in those with normal intellectual functioning than in their siblings or in cases with intellectual disability.  Patients... Read more »

Vitamin D is the New Hormone

A vitamin is an essential nutrient that our body must obtain from food. Yet, this is not the case for vitamin... Read more »

Researchers Find Link Between Processed Foods and Autism

A preservative in processed foods could hold one of the clues to the rising rates of autism in the U.S., according... Read more »

Autism Mostly Caused By Genetics, Study Finds

In what’s being called the largest study of its kind, researchers say that the likelihood of developing autism is overwhelmingly rooted... Read more »

Inbrija

The US Food and Drug Administration has approved levodopa inhalation powder (Inbrija, Acorda Therapeutics) for intermittent treatment of “off” episodes in... Read more »

Zonisamide Shows Promise in Curbing Parkinson’s Symptoms

People with Parkinson’s disease who received zonisamide, in addition to levodopa and other anti-Parkinson’s medications had significantly reduced odds of developing... Read more »

Bipolar Disorder and Heightened Risk for Parkinson Disease

Parkinson disease has a complicated relationship with psychiatric disorders. Some medications used to treat this disease can lead to psychosis or... Read more »

Cholesterol Medicine May Help Children with Fragile X Syndrome

Researchers from the University of Edinburgh report that lovastatin (Mevacor, Altocor, etc.) corrected learning and memory problems in rats with a... Read more »

Cognitive Decline Over Time in Schizophrenia and Other Psychoses

Decline in several cognitive domains continues for a decade after disease onset and is not attributable to medication effects.  Patients with... Read more »